Salario de Cirujano en California (2026)

Surgery is FLSA-exempt salaried — there's no overtime pay, just RVU productivity, call coverage, and partnership distribution. The new federal OBBBA "No Tax on Overtime" deduction (2025–2028) doesn't apply to attendings. Don't waste time on it. The real California surgeon levers are productivity bonus, ASC partnership equity, the cash-balance plan stack, and — for academic faculty — the PSLF student-loan-forgiveness path. Each of these is worth more annually than the OBBBA cap anyway.

RVU productivity is how CA surgeon comp flexes above base. Work-RVU bonus typically pays $55–$75/RVU above threshold; a high-volume orthopedic surgeon at 12,000 work-RVU/year clears $700K–$900K in base + RVU before any ASC distribution. Call coverage adds $1,500–$5,000 per 24-hour shift at Level I trauma centers — cardiothoracic and neurosurgery on-call premiums add $80K–$200K/year.

ASC (Ambulatory Surgical Center) partnership is the biggest wealth-build for CA surgeons in orthopedic, GI, pain, ophthalmologic, urologic, and plastic specialties. Buy-in $200K–$1.5M (Stark-Law fair-market value) generates $80K–$400K/year in facility-fee distribution on top of clinical comp. Distribution flows through S-corp or partnership LLC; facility-fee / rental income may qualify as non-SSTB QBI federally (CA doesn't conform to QBI at all). The PE consolidator exit (KKR, Blackstone, Welsh Carson buying ASC chains 2022–2026) is the wealth-event senior partners target — $500K–$3M+ capital gain, federal LTCG 23.8%, full 13.3% CA layer if still resident.

The cash-balance defined-benefit plan + Solo 401(k) stack is the dominant retirement architecture for California 1099 / S-corp surgeons at age 50+. Stack the Solo 401(k) at $70K/year ($24.5K elective + $47.5K profit-share), then the cash-balance plan at $200K–$300K/year deductible (the cash-balance limit grows with age — at 50 it's roughly $200K, at 60 it's closer to $325K). Total annual pre-tax shelter for a 55-year-old California cardiothoracic surgeon: $270K–$370K. At a 50%+ combined federal+CA marginal rate, that's $135K–$200K of current-year tax saved. Run the same play for 10–15 peak years and the compounded retirement assets are $5M–$8M. Most California surgeons either have this set up by year 8 of attending or are leaving real money on the table.

S-corp election at $400K+ net SE saves $8K–$20K/year in SE tax through reasonable-comp + distribution split (typical surgeon ratio 50-70% comp). The California friction not present in TX/FL: $800/year minimum franchise tax + 1.5% CA S-corp net income tax. PSLF at UCSF / Stanford / UCLA / UCSD / USC Keck / Cedars-Sinai / Kaiser non-profit = $300K–$500K of federal student loan debt forgiven tax-free at 120 qualifying payments. Pair with 403(b) + 457(b) + UCRP pension and the academic comp gap (15-25% below private) closes substantially.

AB 35 MICRA reform (2023–2033 phase-in) is the malpractice-cost story. The historical $250K cap on non-economic damages is rising to $750K (injury) / $1M (death) over 10 years. CA neurosurgery / cardiothoracic / OB-Gyn 2026 premiums: $60K–$130K/year, projected $90K–$200K by 2030. TX (HB 4 cap $250K + $750K) and FL (no cap post-2017) run $25K–$60K equivalent — the malpractice differential alone is a reason some senior CA surgeons relocate before retirement.

California is genuinely the deepest surgical training and practice market in the world. UCSF + Stanford + UCLA + UCSD + USC Keck + Cedars-Sinai + Hoag + Scripps — the academic depth, fellowship pipeline, subspecialty volume, and research infrastructure are real, and most senior US surgeons spent at least their fellowship year here. If you want to do high-volume cardiothoracic, complex neurosurgery, or orthopedic spine in 2026, California is one of about three places that can support the case mix.

Housing absorbs the comp premium quickly at every tier except the cosmetic plastic owner-operator. Bay Area: Atherton $7M+, Palo Alto $3.5M, SF Pacific Heights $4M–$8M+. Most Bay Area surgeons under 45 buy Burlingame / San Mateo / East Bay (Walnut Creek / Lafayette / Orinda) at $1.8M–$3M on academic faculty comp. LA Westside (Brentwood / Pacific Palisades / Bel-Air) at $4M–$15M+ matches Beverly Hills cosmetic owner-operator. San Diego (La Jolla / Del Mar) at $3M–$10M+.

Prop 13 is the sleeper benefit. Once you buy a primary residence, taxable assessed value locks in and can only rise 2%/year — after 15–20 years, long-tenured CA surgeon homeowners pay property tax 60–80% below newer neighbors. Combined with the homeowner's exemption, it quietly compounds wealth. It's why senior CA surgeons don't move during career — they're frozen on tax in a way that can't be replicated by relocating.

The late-career retirement-relocation play is the structural counterweight. Senior surgeons sitting on $5M–$15M of unrealized ASC equity + $5M–$8M cash-balance + brokerage and real estate face 13.3–14.3% CA tax on essentially every realization event if they stay. Relocating to TX / FL / NV / TN 2–3 years before the PE consolidator buys the ASC, before the cash-balance plan terminates, saves $700K–$2M+. The catch is the FTB audit at $5M+ domicile changes — sell the CA primary, register the cars, change voter reg, document the dentist and the dog. Half-measures get clawed back.

Years 1–9 (med school + residency + fellowship). 4 years med school + 5–9 years residency (general 5, neuro 7, cardiothoracic 7–8, plastic 6–8) + 1–3 years fellowship. PGY1 ACGME stipend at CA programs runs $75K–$95K — well below cost of living. Most CA surgical residents finish with $300K–$500K in federal student loan debt. PSLF at non-profit academic hospital = $0 tax-free forgiveness at 120 qualifying payments — the highest-value financial decision available to academic-track surgeons.

Years 1–3 attending ($380K–$485K). Hospital-employed W-2 base or $350K–$425K + revenue-sharing at private group with stub-partnership track. Cash-balance plan eligibility typically begins year 2–3. Most new attendings rent through year 1–2, then buy a $1.5M–$2.5M starter home in suburban metro (Burlingame / Walnut Creek / Pasadena / Encinitas / Carmel Valley). Backdoor Roth starts immediately.

Years 4–10 attending ($525K–$785K TC). Subspecialty premium materializes: ortho $625K, cardiothoracic $720K, neurosurgery $785K. Private-group partnership buy-in ($200K–$1.5M) at year 3–5 — financed via group loan, paid out of distribution. ASC partnership equity ($150K–$500K) at year 5–7. Cash-balance + Solo 401(k) at age 45–55 = $270K–$370K/year shelter. By year 10 mid-career, CA surgeon net worth typically $2M–$8M.

Years 10+ (senior partner / department chair / late career). $700K–$1.5M+ TC for senior partners; Beverly Hills cosmetic plastic owner-operators routinely clear $1.5M–$3.5M+. Academic department chairs at UCSF / Stanford / UCLA $900K–$1.5M with administrative LTI + 403(b) / 457(b). Many senior surgeons divest ASC equity to PE consolidator (KKR / Blackstone / Welsh Carson) realizing $500K–$3M+ capital gain — federal LTCG 23.8%, full 13.3% CA layer if still resident. By mid-60s, typical retiree liquid net worth $8M–$30M+. The dominant retirement-relocation play is TX / FL / NV / TN for the cash-balance distribution + ASC final-payout + brokerage realization years — saves $1M–$3M state tax over the windup. Every senior California surgeon eventually has Naples, Sarasota, Austin, or Las Vegas in the conversation.